<DOC>
	<DOCNO>NCT00539773</DOCNO>
	<brief_summary>Phase II Trial concurrent administration intravesical BCG &amp; Interferon treatment prevention recurrence superficial transitional carcinoma urinary bladder .</brief_summary>
	<brief_title>Phase II Trial Concurrent Administration Intravesical BCG &amp; Interferon Treatment Prevention Recurrence Superficial Transitional Carcinoma Urinary Bladder</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Patients superficial transitional carcinoma urinary bladder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>